JP2022548247A5 - - Google Patents

Info

Publication number
JP2022548247A5
JP2022548247A5 JP2022516117A JP2022516117A JP2022548247A5 JP 2022548247 A5 JP2022548247 A5 JP 2022548247A5 JP 2022516117 A JP2022516117 A JP 2022516117A JP 2022516117 A JP2022516117 A JP 2022516117A JP 2022548247 A5 JP2022548247 A5 JP 2022548247A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
formula
alkyl group
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022516117A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548247A (ja
JP7680433B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/075458 external-priority patent/WO2021048342A1/en
Publication of JP2022548247A publication Critical patent/JP2022548247A/ja
Publication of JP2022548247A5 publication Critical patent/JP2022548247A5/ja
Application granted granted Critical
Publication of JP7680433B2 publication Critical patent/JP7680433B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516117A 2019-09-13 2020-09-11 抗菌化合物 Active JP7680433B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19197183.7 2019-09-13
EP19197183 2019-09-13
PCT/EP2020/075458 WO2021048342A1 (en) 2019-09-13 2020-09-11 Antibacterial compounds

Publications (3)

Publication Number Publication Date
JP2022548247A JP2022548247A (ja) 2022-11-17
JP2022548247A5 true JP2022548247A5 (enExample) 2023-09-19
JP7680433B2 JP7680433B2 (ja) 2025-05-20

Family

ID=67956507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516117A Active JP7680433B2 (ja) 2019-09-13 2020-09-11 抗菌化合物

Country Status (11)

Country Link
US (1) US20220340564A1 (enExample)
EP (1) EP4028399B1 (enExample)
JP (1) JP7680433B2 (enExample)
KR (1) KR102955654B1 (enExample)
CN (1) CN114423758B (enExample)
AU (1) AU2020346370B2 (enExample)
BR (1) BR112022003799A2 (enExample)
CA (1) CA3149868A1 (enExample)
ES (1) ES2978573T3 (enExample)
MX (1) MX2022003037A (enExample)
WO (1) WO2021048342A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20181352A1 (es) 2015-09-17 2018-08-22 Marvin J Miller Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias
WO2022194803A1 (en) * 2021-03-16 2022-09-22 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
CA3234515A1 (en) 2021-10-28 2023-05-04 Jose Manuel Bartolome-Nebreda Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
JP2026525955A (ja) 2023-07-18 2026-08-04 ヤンセン ファーマシューティカ エヌ.ベー. ベダキリン、プレトマニド又はデラマニド、及びシトクロムbc1阻害剤を含む、少なくとも三種の抗生物質の組み合わせ製品、並びにマイコバクテリア感染症の治療におけるそれらの使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1527050T1 (sl) 2002-07-25 2010-08-31 Janssen Pharmaceutica Nv Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji
RU2576662C2 (ru) 2010-03-18 2016-03-10 Энститю Пастер Корея Противоинфекционные соединения
US8569283B2 (en) 2011-09-01 2013-10-29 Valentina Molteni Compounds and compositions as c-Kit kinase inhibitors
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
JP6483610B2 (ja) * 2012-07-18 2019-03-13 ユニバーシティ オブ ノートルダム デュ ラック 5,5−ヘテロ芳香族抗感染症化合物
WO2015014993A2 (en) 2013-08-02 2015-02-05 Institut Pasteur Korea Anti-infective compounds
CN105524058B (zh) * 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用
MD3316969T2 (ro) 2015-07-02 2022-07-31 Janssen Sciences Ireland Unlimited Co Compuși antibacterieni
PE20181352A1 (es) 2015-09-17 2018-08-22 Marvin J Miller Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias
MA45377A (fr) 2016-06-16 2019-04-24 Janssen Sciences Ireland Unlimited Co Composés hétérocycliques en tant qu'agents antibacteriens
EP3472152A1 (en) 2016-06-16 2019-04-24 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacte rials
WO2018084809A1 (en) * 2016-11-02 2018-05-11 Nanyang Technological University Methods for the treatment or prevention of mycobacterial infections

Similar Documents

Publication Publication Date Title
RU2322444C2 (ru) Соединения оксазолидинона, обладающие антибактериальной активностью, способ получения (варианты) и фармацевтическая композиция на их основе
AR059523A2 (es) Azalidas de 13 miembros macrolidos, composiciones farmaceuticas, su uso en la preparacion de medicamentos para el tratamiento de infecciones y procedimientos para preparar estos compuestos.
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
JP2019518050A5 (enExample)
JP2006501181A5 (enExample)
RU2008136187A (ru) Новое производное кумарина, обладающее противоопухолевой активностью
JP2021535112A5 (enExample)
JP2023520396A5 (enExample)
KR950702982A (ko) 치환된 티아졸리딘디온 유도체(Substituted Thiazolidinedione Derivatives)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
CA2547347A1 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
JP2005537323A5 (enExample)
JP2015512435A5 (enExample)
JP2022510925A5 (enExample)
RU2003110577A (ru) Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами
JP2004525876A5 (enExample)
KR900018134A (ko) 레트로바이러스성 프로테아제 억제 화합물
JP2009529059A5 (enExample)
JP2019500387A5 (enExample)
JP2005517006A5 (enExample)
RU2394028C2 (ru) Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы
CA2494832A1 (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2005519885A5 (enExample)
JP2024540052A5 (enExample)
JP2022529309A5 (enExample)